Recruiting
Phase 2

Dexlansoprazole

Sponsor:

Takeda

Code:

NCT02615184

Conditions

Erosive Esophagitis

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

Dexlansoprazole

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Takeda on 2024-09-26.